Product Categories
Country: | China |
---|---|
Tel: | 400-400-8210725 |
Mobile: | 17717813675 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
Quinoxaline-2,3(1H,4H)-dione | C8H6N2O2 | 6287-20-3 | Details |
7-Acetoxy-3-formylchromone | C12H8O5 | 42059-49-4 | Details |
2,7-Dibromo-9,9-di-p-tolyl-9H-fluorene | C27H20Br2 | 357645-37-5 | Details |
Thiazol-5-ylmethyl ((2S,3S,5S)-5-((S)-2-(3,3-dimethylureido)-3-methylbutanamido)-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate (Ritonavir Impurity) | C31H41N5O5S | 959351-57-6 | Details |
2-(2,4-Difluorophenyl)propane-1,2,3-triol (Efinaconazole Impurity) | C9H10F2O3 | 173837-65-5 | Details |
5,5′-(21H,23H-Porphine-5,15-diyl)bis[1,3-benzenedicarboxylic acid] | C36H22N4O8 | 1337989-45-3 | Details |
Benzo[c][1,2,5]thiadiazole-4,7-diamine | C6H6N4S | 19951-39-4 | Details |
2-(1-(2-Aminoethyl)cyclohexyl)acetic acid (Gabapentin Impurity) | C10H19NO2 | 1500558-49-5 | Details |
(R)-N-(1-(Naphthalen-1-yl)ethyl)-3-phenylpropan-1-amine hydrochloride (Cinacalcet Impurity) | C21H24ClN | 938177-81-2 | Details |
(S)-Fmoc-2-amino -5-(3,5-difluorophenyl)pentanoic acid | C11H13F2NO2 | 2349727-63-3 | Details |
Fmoc-2-amino-5-phenyl(2,3-Difluoro)-L-pentanoic acid | C26H23F2NO4 | 2349313-65-9 | Details |
PFDP | (C42H43N)N | 856893-75-9 | Details |
Tert-butyl 1-phenyl-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate | C17H21N3O2 | 1075729-08-6 | Details |
(R)-4-methoxy-2,3-dihydro-1H-inden-1-amine | C10H13NO | 1217445-49-2 | Details |
DTFCO8-2Br | C15H17Br2FOS2 | 1309764-86-0 | Details |
2-Nitro-1-(oxiran-2-ylmethyl)-1H-imidazole | C6H7N3O3 | 13551-90-1 | Details |
4-((1-Methoxy-1-oxobutan-2-yl)amino)butanoic acid (Levetiracetam Impurity) | C9H17NO4 | 1543300-90-8 | Details |
2-(4-((2-Hydroxycyclopentyl)methyl)phenyl)propanoic acid (Loxoprofen Impurity) | C15H20O3 | 83599-40-0 | Details |
(Benzene-1,2,4,5-tetrayltetrakis(methylene))tetraphosphonic acid | C10H18O12P4 | 69303-28-2 | Details |
Fmoc-2-amino-5-phenyl(2,5-Difluoro)-L-pentanoic acid | C26H23F2NO4 | 2350817-95-5 | Details |
Ethyl 1-(piperidine-4-carbonyl)piperidine-4-carboxylate (Avatrombopag Impurity) | C14H24N2O3 | 901314-75-8 | Details |
4-Chloro-5-nitro-2-(propylthio)pyrimidine (Ticagrelor Impurity) | C7H8ClN3O2S | 2518331-26-3 | Details |
2',5'-Bis((4-aminophenyl)ethynyl)-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde | C36H24N2O2 | 2375652-87-0 | Details |
2-Bromo-1-(3-fluoropyridin-2-yl)ethan-1-one | C7H5BrFNO | 1044270-51-0 | Details |
(S)-3-amino-1-chloro-4-methylpentan-2-one hydrochloride | C6H12ClNO.ClH | 107831-79-8 | Details |
1,1-Dichloro-3,3-dimethylbutane | C6H12Cl2 | 6130-96-7 | Details |
4-(6-Carboxy-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,3,4]oxadiazino[6,5,4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide (Marbofloxacin Impurity) | C17H19FN4O5 | 194023-72-8 | Details |
1,1''-(1,4-Phenylenebis(methylene))bis(([4,4'-bipyridin]-1-ium)) | C28H24N4+2 | 108861-19-4 | Details |
1-Bromo-4-(2-butyloctyl)benzene | C18H29Br | 2243732-54-7 | Details |
4-((1-Amino-1-oxobutan-2-yl)amino)butanamide (Levetiracetam Impurity) | C8H17N3O2 | 1341459-52-6 | Details |
1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazole 4-oxide (Efinaconazole Impurity) | C13H12F2N6O2 | 1997296-62-4 | Details |
(R,Z)-N-(3-Chloroallyl)-2,3-dihydro-1H-inden-1-amine hydrochloride (Rasagiline Impurity) | C12H15Cl2N | 1175018-80-0 | Details |
Fmoc-D-Ala(tetrahydropyran-4-yl)-OH | C23H25NO5 | 1879080-16-6 | Details |
5,5'-Di([1,1'-biphenyl]-4-yl)-2,2'-bithiophene | C32H22S2 | 175850-28-9 | Details |
2-(Chloromethyl)-5-(methylsulfonyl)pyridine | C7H8ClNO2S | 1196151-88-8 | Details |
5,5',5''-(4,4',4''-(Benzene-1,3,5-triyl)tris(1H-1,2,3-triazole-4,1-diyl))triisophthalic acid | C36H21N9O12 | 1334547-47-5 | Details |
[1,1'-Biphenyl]-2,3',5,5'-tetracarboxylic acid | C16H10O8 | 1515946-99-2 | Details |
4-[[2,3,4,4,6-Pentakis(4-carboxyphenoxy)-1,3,5-triaza-2,4λ5,6-triphosphacyclohex-4-en-1-yl]oxy]benzoicacid | C42H30N3O18P3 | 69322-61-8 | Details |
2-Iodooctane | C8H17I | 557-36-8 | Details |
Fmoc-2-amino-5-phenyl(3,4-Difluoro)-L-pentanoic acid | C26H23F2NO4 | 2350133-60-5 | Details |
5-Chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(dimethylamino)nicotinamide (Avatrombopag Impurity) | C25H30Cl2N6OS2 | 2626934-45-8 | Details |
2-(3-((1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid (Benazepril Impurity) | C24H28N2O5 | 98626-50-7 | Details |
1,4-Di-tert-butoxy-2,3,5,6-tetrafluorobenzene | C14H18F4O2 | 121088-09-3 | Details |
(R)-cyclopropyl(2,4-dimethylphenyl)methanamine | C12H17N | 1213360-96-3 | Details |
2TOMe-2Sn | C16H26O2S2Sn2 | 1248460-50-5 | Details |
DTCOO26-CHO-Br | C16H19BrO3S2 | 1848245-23-7 | Details |
[2,2'-Bipyridine]-3,3',6,6'-tetracarboxylic acid | C14H8N2O8 | 863000-84-4 | Details |
1-(Benzo[d][1,3]dioxol-5-yl)thiourea | C8H8N2O2S | 65069-55-8 | Details |
(R)-2-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride (Quinapril Impurity) | C25H31ClN2O5 | 103775-06-0 | Details |
TPD1014-2Br | C30H49Br2NO2S | 1640286-62-9 | Details |
N,N-Diethyl-2-(2-methoxy-5-(methylsulfonyl)benzamido)ethanamine oxide (Tiapride Impurity) | C15H24N2O5S | 63484-11-7 | Details |
1,1,2,2-Tetrakis(4-methylphenyl)-1,2-ethanediol | C30H30O2 | 913-86-0 | Details |
Fmoc-(S)-2-amino-3-(2-oxopyrrolidin-1-yl)propanoic acid | C22H22N2O5 | 2350069-82-6 | Details |
Fmoc-Ser(cyclopentyl)-OH | C23H25NO5 | 2382243-79-8 | Details |
(R)-Fmoc-2-Amino-5-(2,4-dichlorophenyl)pentanoic acid | C26H23Cl2NO4 | 2349593-81-1 | Details |
3-Sulfophthalic acid | C8H6O7S | 67892-43-7 | Details |
1-(4-Chloro-2-methylphenyl)thiourea | C8H9ClN2S | 63980-71-2 | Details |
N′-(1,1-Dimethylethyl)-N,N-dimethylmethanimidamide | C7H16N2 | 23314-06-9 | Details |
2-Acetylmalononitrile | C5H4N2O | 1187-11-7 | Details |
(S)-Fmoc-α-Me-Trp-OH | C27H24N2O4 | 2244235-26-3 | Details |
2',4',6'-Trifluoro-5'-(4-formylphenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarbaldehyde | C27H15F3O3 | 2088007-05-8 | Details |
BT2F-2Th812Sn | C60H102F2N2S3Sn2 | 2376104-24-2 | Details |
2',5'-Bis((ethylthio)methyl)-[1,1':4',1''-terphenyl]-4,4''-diamine | C24H28N2S2 | 2231404-37-6 | Details |
4-Bromo-7-chloro-1H-pyrrolo[3,2-c]pyridine-3-carbaldehyde | C8H4BrClN2O | 1000341-99-0 | Details |
7-(3-(Trifluoromethyl)phenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide | C14H9F3N4O | 115930-92-2 | Details |
(S)-Boc-2-amino-3,3-dimethyl-pent-4-enoicacid | C12H21NO4 | 676629-90-6 | Details |
5-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroisoquinoline | C11H14BrN | 1203684-57-4 | Details |
4,4′-(7,8-Dihydro-21H,23H-porphine-5,15-diyl)bis[benzoic acid] | C34H24N4O4 | 1797416-17-1 | Details |
Th26-CHO-B | C19H31BO3S | 2344786-93-0 | Details |
2,5-Di(2H-tetrazol-5-yl)terephthalic acid | C10H6N8O4 | 2417761-51-2 | Details |
(1,4-Dioxane-2,5-diyl)dimethanol | C6H12O4 | 14236-12-5 | Details |
(8R,9S,10R,13S,14S,17R)-17-Acetyl-10,13-dimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate (Chlormadinone Acetate Impurity) | C23H30O4 | 425-51-4 | Details |
2-(Diphenylamino)pyrimidine-5-carboxylic acid | C17H13N3O2 | 1316216-06-4 | Details |
Boc-3,5-Dimethyl-L-Tyrosine | C16H23NO5 | 1212941-74-6 | Details |
3T8-CHO | C29H40OS3 | 1342311-47-0 | Details |
N4,N4,N4',N4'-Tetrakis(4-(pyridin-4-yl)phenyl)-[1,1'-biphenyl]-4,4'-diamine | C56H40N6 | 1471200-74-4 | Details |
1-(Piperidin-1-yl)propan-2-ol | C8H17NO | 934-90-7 | Details |
Fmoc-3,5- Dimethyl-L-Tyrosine | C26H25NO5 | 369401-19-4 | Details |
α,α,α',α'-Tetramethyl-1,3-benzenedipropionitrile | C16H20N2 | 69774-36-3 | Details |
DPPBr6-2Br | C26H28Br4N2O2S2 | 1799951-38-4 | Details |
(4-Methylenepiperidin-1-yl)(phenyl)methanone (Efinaconazole Impurity) | C13H15NO | 188904-84-9 | Details |
5-(4-Carboxyphenyl)picolinic acid | C13H9NO4 | 1261898-79-6 | Details |
(2R,3R,4R,5R)-6-Nitrohexane-1,2,3,4,5-pentaol | C6H13NO7 | 14199-83-8 | Details |
9,10-Dihydro-9,10-[1,2]benzenoanthracene-2,7,14-triamine | C20H17N3 | 58519-05-4 | Details |
2-((8R,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl)acetonitrile (Dienogest Impurity) | C20H25NO2 | 16669-06-0 | Details |
(3S,5aS,9aS,10aS)-3-Methyldecahydropyrazino[1,2-a]indole-1,4-dione (Perindopril Impurity) | C12H18N2O2 | 2165676-00-4 | Details |
1,2-Bis(4-(2-((2,4-dimethylphenyl)thio)phenyl)piperazin-1-yl)ethanone (Vortioxetine Impurity) | C38H44N4OS2 | 2476761-84-7 | Details |
(8R,9S,13S,14S,16S,17S)-13-Methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,16,17-triol (Estriol Impurity) | C18H24O3 | 793-89-5 | Details |
Methyl 1-chloro-4-hydroxyisoquinoline-3-carboxylate | C11H8ClNO3 | 223388-20-3 | Details |
(2S,3aS,7aS)-1-((2S)-2-((Z)-3-Cyclohexyl-2-(cyclohexylimino)-4-oxo-5-propylimidazolidin-1-yl)propanoyl)octahydro-1H-indole-2-carboxylic acid (Perindopril Impurity) | C30H48N4O4 | 353777-64-7 | Details |
9-Phenyl-9H-carbazole-3,6-dicarboxylic acid | C20H13NO4 | 1595292-24-2 | Details |
Benzo[1′′,2′′:4,5;4′′,5′′:4′,5′]bissilolo[3,2-b:3′,2′-b′]dithiophene, 4,4,9,9-tetrahexyl-4,9-dihydro-2,7-bis(trimethylstannyl)- | C44H74S2Si2Sn2 | 1569453-45-7 | Details |
(S)-2-(o-tolyl)pyrrolidine | C11H15N | 914299-82-4 | Details |
1,4-Di(1H-1,2,3-triazol-5-yl)benzene | C10H8N6 | 935747-92-5 | Details |
ThCl-2Br | C4HBr2ClS | 32431-91-7 | Details |
Fmoc-5-oxo-5-(piperidin-1-yl)-L-Norvaline | C25H28N2O5 | 2559759-55-4 | Details |
Product Total: Product Page: | ||||
231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 |